about
Influence of diabetes mellitus on heart failure risk and outcomeA Drosophila model of high sugar diet-induced cardiomyopathyPomegranate flower: a unique traditional antidiabetic medicine with dual PPAR-alpha/-gamma activator propertiesDecrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic ratsIncreased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucoseLimits of a localized magnetic resonance spectroscopy assay for ex vivo myocardial triacylglycerol.Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia.Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease.Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathwayHeart failure in the diabetic population - pathophysiology, diagnosis and management.Cardiac-specific overexpression of HIF-1{alpha} prevents deterioration of glycolytic pathway and cardiac remodeling in streptozotocin-induced diabetic mice.Race/ethnic disparities in left ventricular diastolic function in a triethnic community cohort.Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategiesEffects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus.Crucial role of calcium-sensing receptor activation in cardiac injury of diabetic rats.Acetyl-l-carnitine and oxfenicine on cardiac pumping mechanics in streptozotocin-induced diabetes in male Wistar ratsCardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in ratsGlobal Transcriptomic Profiling of Cardiac Hypertrophy and Fatty Heart Induced by Long-Term High-Energy Diet in Bama Miniature PigsMetabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes.Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemiaDiacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.Pathophysiological effects of different risk factors for heart failurePredictors and prevention of diabetic cardiomyopathy.Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes.Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease.Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients?The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophyIs there a link between glucose levels and heart failure? An update.Insulin says NO to cardiovascular disease.Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy.Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfuntion.Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? An observational study from the Swedish Heart Failure Registry.Mitochondrial miRNAs in diabetes: just the tip of the iceberg.
P2860
Q24800363-7FF4E0C4-8F12-4EE0-870F-59273F8DDAD0Q27325739-D8568806-118D-4173-BC38-9257421DE496Q28261771-EC800254-59BC-4CAE-A37C-6A9221DB86B5Q28572349-67AD4AA5-4862-41D4-9BF1-80D2FFBFF033Q28573520-345D96D6-2E8C-4E31-959D-66552435C88CQ30489159-875D09C3-61A3-4983-B30D-5C357D5E6046Q31940192-0281FF6E-A881-478C-AC19-3A0DCECD4E89Q33803815-457DA26D-1581-4C30-92E8-D2E7E6AFC28CQ33835169-66887E67-BD12-479D-821C-2850D7BF70F7Q33935375-88224ED3-F420-4324-B1C9-F1EEBD13B672Q33947175-DD6734D9-331A-47D0-BFA8-C60554DECD65Q33968659-9F94ADCC-9938-4C39-BF60-A5C4F529ED5BQ33991754-11EBC0AF-ACDB-4DD0-B405-93F507C895A0Q34245190-235A4655-4F7B-4F20-86F6-EFC8BEF8C75FQ34506453-25D9A5F9-84BF-4938-B67F-9A8AF9F2289FQ34746664-8027299A-808F-4822-BAB9-6E29C771A4A5Q34905231-4737B60D-1271-46AF-8EC1-407A755E8600Q35646400-62235DDE-5DE5-4271-B26F-946C398F0502Q35687936-8C254180-4EE9-4D67-BA7C-75BF608FC6AAQ35780290-BA36DFCB-127C-43BA-873F-F30E3625FE83Q35855934-28F7AAFA-321D-46E2-A1A5-40E42D3D3B10Q36070922-1B6C1218-3F26-433A-ADC0-5CECF0CE47FFQ36492259-88D712D1-6457-4C90-845D-7B490E1F1C48Q36709180-85E37666-655E-4606-8BCF-297F833257B4Q36776922-902D0CBE-82C4-4A61-A3B5-E8A271BD8099Q37016716-2DD11DC4-818B-44BA-BF64-1ACF027074CEQ37158878-62C84304-F163-40AB-A092-C1C65F6FF2C0Q37724503-6AAFAAB5-B562-4235-8251-C2C6D32BAAF7Q37730496-0D4973EC-2303-4B62-9942-AF1B99E86E69Q37778757-D9C520F6-F4C4-49EF-BBA5-5DD11179590FQ37807194-A46953E7-2B7F-41A7-9253-2ECCBB621EA5Q37832957-BB9B1A95-D826-43FE-A046-568ACD76B31BQ37882500-D18E8857-564E-4CF8-834D-3AA26C134492Q37951439-B0C62F43-7C49-464A-888A-DC7C0850F259Q38061830-3DD11C40-6633-482C-B77E-0AB76D87CBFEQ38083574-CA361C60-55D7-4230-9A4F-2D8CAC0CB8B7Q38113247-F31F08AB-AA87-418C-AA35-D64F0AC9B741Q39080574-5CB5447E-8CCA-4AB6-AD29-7324EDFA2A38Q39263859-BF1CAEE2-37D0-441D-925C-BB4757E89822Q39280722-9CD902A1-D934-4FFE-91A7-238CE5E5C983
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Metabolic disturbances in diabetic cardiomyopathy.
@en
type
label
Metabolic disturbances in diabetic cardiomyopathy.
@en
prefLabel
Metabolic disturbances in diabetic cardiomyopathy.
@en
P2093
P356
P1476
Metabolic disturbances in diabetic cardiomyopathy.
@en
P2093
P2888
P356
10.1023/A:1006882805197
P577
1998-03-01T00:00:00Z
P6179
1041489752